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TRPM6 and TRPM7 differentially 
contribute to the relief of 
heteromeric TRPM6/7 channels 
from inhibition by cytosolic Mg2+ 
and Mg·ATP
Silvia Ferioli1, Susanna Zierler  1, Joanna Zaißerer1, Johann Schredelseker1, Thomas 
Gudermann1,2,3 & Vladimir Chubanov  1
TRPM6 and its homologue TRPM7 are α-kinase-coupled divalent cation-selective channels activated 
upon reduction of cytosolic levels of Mg2+ and Mg·ATP. TRPM6 is vital for organismal Mg2+ balance. 
However, mechanistically the cellular role and functional nonredundancy of TRPM6 remain 
incompletely understood. Comparative analysis of native currents in primary cells from TRPM6- versus 
TRPM7-deficient mice supported the concept that native TRPM6 primarily functions as a constituent 
of heteromeric TRPM6/7 channels. However, heterologous expression of the human TRPM6 protein 
engendered controversial results with respect to channel characteristics including its regulation by 
Mg2+ and Mg·ATP. To resolve this issue, we cloned the mouse TRPM6 (mTRPM6) cDNA and compared 
its functional characteristics to mouse TRPM7 (mTRPM7) after heterologous expression. Notably, we 
observed that mTRPM6 and mTRPM7 differentially regulate properties of heteromeric mTRPM6/7 
channels: In the presence of mTRPM7, the extreme sensitivity of functionally expressed homomeric 
mTRPM6 to Mg2+ is tuned to higher concentrations, whereas mTRPM6 relieves mTRPM7 from the 
tight inhibition by Mg·ATP. Consequently, the association of mTRPM6 with mTRPM7 allows for high 
constitutive activity of mTRPM6/7 in the presence of physiological levels of Mg2+ and Mg·ATP, thus 
laying the mechanistic foundation for constant vectorial Mg2+ transport specifically into epithelial cells.
Transient receptor potential melastatin 6 (TRPM6) and 7 (TRPM7) are extraordinary proteins comprising 
two distinct functional moieties: an ion channel segment and an α-type serine/threonine kinase domain1, 2. 
Experiments with TRPM7-deficient cell lines revealed that TRPM7 regulates salient cell processes such as Mg2+ 
metabolism3–5, Ca2+ signaling6–8, chromatin modification9, cell motility10–13, proliferation6–8, 14–16 and differentia-
tion17–19. Genetic inactivation of Trpm7 in mice results in early embryonic death17, 19. Conditional tissue-specific 
inactivation of Trpm7 in mice showed that TRPM7 plays a critical role in morphogenesis of various internal 
organs19–21. In contrast to global Trpm7 null mutations, specific genetic inactivation of the kinase activity (referred 
to a ‘kinase-dead’ Trpm7 mutation) does not impede embryonic development22. Adult ‘kinase-dead’ Trpm7 mice 
are more resistant to dietary Mg2+ deprivation in terms of survival and develop a mild form of organismal Mg2+ 
deficiency23. These results were interpreted to mean that the TRPM7 kinase moiety is necessary for an adap-
tive systemic response to Mg2+ deficiency23. Recently, a search for genetic forms of macrothrombocytopenia in 
humans resulted in the discovery of two pedigrees harbouring loss-of-function point mutations in the human 
TRPM7 gene24. These patients presented with impaired thrombopoiesis due to altered cellular Mg2+ homeostasis 
and cytoskeletal architecture24.
Recombinant TRPM7 proteins from several vertebrate species have been cloned and functionally character-
ized2. With minor exceptions25, key channel properties of TRPM7 orthologues were found to be highly conserved. 
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Briefly, recombinant TRPM7 forms homotetrameric channel complexes highly permeable to Ca2+, Mg2+ and 
Zn2+ 15, 26–28. Intracellular and extracellular Mg2+ regulates TRPM7 channel activity. External Mg2+ acts as a per-
meant blocker of the channel pore15, 26–29. Internally applied Mg2+ ([Mg2+]i) and Mg·ATP ([Mg·ATP]i) inhibit 
TRPM7 currents15. Accordingly, cytosolic concentrations of Mg·ATP and free Mg2+ have been suggested as key 
feedback regulators of TRPM7 function implying that depletion of intracellular Mg2+ and Mg·ATP promotes 
TRPM7-mediated uptake of extracellular Mg2+ 15. TRPM7 is assumed to be a ubiquitously expressed protein2, and 
endogenous TRPM7 currents, referred to as magnesium nucleotide-regulated metal ion currents (MagNuM)15, 30 
and magnesium-inhibited cation currents (MIC)31, have been detected in all cell types examined so far2.
Loss-of-function mutations in the human TRPM6 gene give rise to autosomal recessive hypomagnesemia, also 
called primary hypomagnesemia type 1, intestinal (HOMG1) or hypomagnesemia with secondary hypocalcemia 
(HSH)32–35. HSH manifests in early infancy with 3- to 10-fold decreased serum Mg2+ concentrations, generalized 
convulsions and muscle spasms. Relief of clinical symptoms can be achieved by administration of high doses of 
Mg2+ 32–35. Unexpectedly, Trpm6 null mice die at embryonic day 12.5 (e12.5)36. Recently, our group employed a 
set of newly generated mouse strains to define the in vivo role of TRPM637. We showed that TRPM6 activity in 
extraembryonic cells of the placenta and yolk sac is essential for embryonic survival of mice37. In adult mice, 
TRPM6 is required in intestinal epithelial cells to maintain organismal Mg2+ balance37. Thus, TRPM6 is a central 
gatekeeper of organismal Mg2+ balance in mammals, and its role cannot be compensated by any other channel 
such as TRPM7. Against the backdrop of the Mg2+-permeable ubiquitously expressed TRPM7, the pivotal role of 
TRPM6 in transporting epithelia is only incompletely understood.
In contrast to the situation with TRPM7, functional characterization of the TRPM6 channel for the most part 
relies on experiments with the human TRPM6 (hTRPM6) cDNA. Our group38, 39 and other investigators40, 41  
observed that hTRPM6 does not efficiently form homomultimeric channels in the plasma membrane, but 
requires TRPM7 to be co-targeted to the cell surface38, 39. Within heteromeric channel complexes (referred to 
TRPM6/7 channels), hTRPM6 increases the current amplitude of TRPM6/7 heteromers as compared to TRPM7 
homomers38, 39. According to other authors42, 43, overexpressed hTRPM6 was able to form homomeric chan-
nels with biophysical characteristics resembling those of TRPM7 including the high channel pore selectivity 
for divalent cations and regulation by [Mg2+]i and [Mg·ATP]i. More recently, it has been reported that expres-
sion of recombinant hTRPM6 gives rise to functional channels only if the hTRPM6 cDNA was inserted into the 
pCINeo-IRES-GFP vector (referred to pCINeo-hTRPM6-IRES-GFP), whereas the same cDNA sequence placed 
in various other expression plasmids did not yield functional hTRPM6 channels27. This feature of hTRPM6 
appears to be unique among TRP proteins, and is still lacking any mechanistic explanation. Furthermore, differ-
ent researchers used the same pCINeo-hTRPM6-IRES-GFP construct to report contradictory results regarding 
the sensitivity of hTRPM6 to [Mg·ATP]i, ranging from full suppression in the presence of physiological levels of 
[Mg·ATP]i44 to complete insensitivity27. Hence, the functional characteristics of recombinant TRPM6 require 
further clarification.
In light of the latter controversy, we opted for the functional analysis of primary cells lacking the endogenous 
mouse TRPM6 (mTRPM6) protein rather than for heterologous expression models and employed trophoblast 
stem (TS) cells derived from Trpm6- and Trpm7-gene deficient mouse blastocysts37. We found that wildtype TS 
cells express both mTRPM6 and mTRPM7, thus mirroring the in vivo situation in transporting epithelial cells 
invariably co-expressing both proteins. We showed that wildtype TS cells exhibit TRPM7-like currents, and that 
genetic inactivation of mTRPM6 reduces the amplitude of these currents. Ionic currents in mTRPM6-deficient 
TS cells were substantially more sensitive to [Mg·ATP]i but equally affected by [Mg2+]i37. In contrast, deletion 
of mTRPM7 resulted in complete disappearance of TRPM7-like currents in TS cells37. These findings support 
the concept that native TRPM6 primarily functions as a subunit of heteromeric TRPM6/7 channels and that 
[Mg·ATP]i most likely is a crucial endogenous regulator of Mg2+ uptake mediated by TRPM6/7 channels.
In the present paper we investigated the role of channel and kinase domains of TRPM6 for the sensitivity 
of TRPM6/7 channels to [Mg2+]i and [Mg·ATP]i. Because the functional consequences of the heterologous 
expression of hTRPM6 are surrounded by considerable controversy, we cloned and functionally characterized 
mTRPM6. Our experiments show that the functional hallmarks of recombinant mTRPM6 in HEK 293 cells reca-
pitulate key findings that emerged from the comparative assessment of mTRPM6- and mTRPM7-deficient TS 
stem cells37, lending credence to the concept that the association of mTRPM6 with mTRPM7 substantially alters 
the regulatory properties of the mTRPM6/7 channels such as their sensitivity to cytosolic Mg·ATP. As a conse-
quence, mTRPM6/7 channels display the unique property of remaining constitutively active in the presence of 
physiological levels of cytosolic Mg2+ and Mg·ATP. Hence, the association of mTRPM6 with mTRPM7 will likely 
lead to a constant Mg2+ uptake, thus providing a mechanistic explanation for efficient Mg2+ transport into epithe-
lial cells only in the presence of mTRPM6.
Results
Cloning and functional expression of recombinant mTRPM6 cDNA. Mus musculus is broadly used 
as an in vivo experimental model to study the physiological role of ion channels including TRPM6 and TRPM7. 
Surprisingly, the murine TRPM6 protein has not been investigated so far in heterologous expression systems. To 
resolve the discrepancies obtained with heterologous expression of human TRPM6, we cloned the mouse TRPM6 
cDNA into pIRES2-EGFP vector and assessed its channel and kinase activities upon transient expression in HEK 
293 cells. We generated a full-length mTRPM6 cDNA (NCBI accession KX375810) using RNA extracted from 
lung tissue. Sequencing confirmed that the obtained mTRPM6 cDNA contains an open reading frame (ORF) 
encoding a 2028-amino acid protein, showing 100% protein sequence identity to an NCBI predicted sequence 
NM_153417.1. Similar to hTRPM645, mTRPM6 comprises a highly conserved N-terminal TRPM domain and 
a typical TRP-like channel segment followed by a C-terminal kinase moiety (Fig. 1A). We used a previously 
reported crystal structure of the mTRPM7 kinase46 to generate a 3D model of the mTRPM6 kinase domain and 
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the location of residues critical for the catalytic activity of the TRPM6 kinase such as K1810 (K1646 in mTRPM7) 
(Fig. 1B)3, 45. In addition, we predicted a residue that is likely to be autophosphorylated in mTRPM6 such as T1730 
(S1567 in mTRPM747) (Fig. 1B).
To evaluate these predictions functionally, we generated mTRPM6 cDNA variants carrying a 
‘kinase-dead’ point mutation (mTRPM6-K1810R) and a variant lacking the predicted autophosphoryla-
tion site (mTRPM6-T1730A). Next, we transiently expressed wildtype mTRPM6, mTRPM6-K1810R and 
mTRPM6-T1730A constructs in HEK 293 cells and assessed the expression levels of the recombinant proteins by 
Figure 1. Domain topology of the cloned murine kinase-coupled channel TRPM6. (A) The plasma membrane 
channel segment of mTRPM6 comprises six transmembrane helices (1–6). A short stretch between the 5th and 
6th helices contains a predicted pore forming loop and a pore helix. A N-terminus of mTRPM6 contains a set 
of predicted ankyrin-like repeats1. The mTRPM6 C-terminus contains a highly conserved transient receptor 
potential (TRP) domain, a coiled-coil (CC) domain, a kinase substrate domain (SD) and a kinase domain (KD). 
(B) 3D model of the mTRPM6 kinase domain generated as described previously1 using annotated coordinates 
of the mouse TRPM7 kinase (PDB code 1IA946). K1810 is a highly conserved residue located in the catalytic 
site of the kinase domain. T1730 is a residue subjected to autophosphorylation by the mTRPM6 kinase. (C) 
Representative Western blot analysis of mTRPM6 variants using the anti-(p)T1730 mTRPM6 antibody (upper 
panel) followed by stripping and re-probing of total mTRPM6 expression levels by anti-mTRPM6 polyclonal 
ab47017 antibody (lower panel). The experiment was repeated three times with similar results. (D) Effect 
of TG100–115 on the autophosphorylation of mTRPM6. HEK 293 cells were transiently transfected with 
mTRPM6. 24 h after transfection, the indicated concentrations of TG100–115 were added to the cell culture 
medium and cells were cultured for additional 12 h and immunoreactivity of mTRPM6 was probed as in (C). A 
representative Western blot is shown. The experiment was repeated two times with similar results.
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Western blot analysis (Fig. 1C). In these experiments, we used a rabbit polyclonal antibody designed as a specific 
probe for mTRPM6 phosphorylated at T1730 ((p)T1730-specific antibody), and a guinea pig anti-TRPM6 pol-
yclonal (ab47017) antibody to identify all mTRPM6 variants. We observed that the ab47017 antibody detected 
comparable protein expression of wildtype mTRPM6, mTRPM6-K1810R and mTRPM6-T1730A and that 
mTRPM6-specific bands were of the expected size (232 kDa) (Fig. 1C). The (p)T1730-specific antibody only 
detected wildtype mTRPM6, but not the mutant variants (Fig. 1C) consistent with the notion that the kinase 
domain autophosphorylates the mTRPM6 protein at position T1730 and that the K1810R mutation ablates the 
catalytic activity of mTRPM6 kinase. Consequently, we asked whether the catalytic activity of mTRPM6 kinase 
can be manipulated in living cells by pharmacological agents. Previously, Davis et al.48 examined 442 kinases to 
assess the overall selectivity of 72 well-defined kinase inhibitors. The authors reported that TG100-115 inactivated 
the purified kinase domain of hTRPM648. We observed that a 12-h culture of mTRPM6-transfected HEK 293 cells 
in the presence of TG100-115 led to suppression of (p)T1730 immunoreactivity (Fig. 1D). Thus, both the K1810R 
mutation and TG100-115 enable to block mTRPM6 kinase.
Assessment of mTRPM6 currents in HEK 293 cells and in trophoblast stem cells. HEK 293 cells 
were transiently transfected with either mTRPM6 or mTRPM7 cDNAs inserted into the pIRES2-EGFP expression 
vector and EGFP-positive cells were examined by patch-clamp analysis. Whole-cell currents were elicited by a 
voltage ramp protocol ranging from −100 to +100 mV and a Mg2+-free internal solution (Fig. 2A). In HEK 293 
cells expressing mTRPM7, outward and inward current amplitudes were small immediately after establishing 
the whole-cell configuration, but rapidly increased presumably due to depletion of intracellular Mg2+. mTRPM7 
currents reached a plateau after ~100 s (Fig. 2A). The current-voltage (I-V) relationships of mTRPM7 currents 
exhibited characteristic features such as small inward and large outward currents with a pronounced rectification, 
and a reversal potential of about 0 mV (Fig. 2C). Notably, mTRPM6-expressing cells also developed inward and 
outward currents (Fig. 2A) with an I-V relationship resembling that of mTRPM7 (Fig. 2C). However, other bio-
physical characteristics of mTRPM6 currents were distinct: While mTRPM6 currents reached a peak at ~100 s of 
recording, they gradually declined thereafter presumably due to an intrinsic inactivation mechanism (Fig. 2B). 
Furthermore, we noted that fully developed outward and inward mTRPM6 currents were substantially (~3-fold) 
smaller when compared to values obtained with mTRPM7 (Fig. 2D).
It has been shown that the endogenous hTRPM7 protein is expressed in HEK 293 cells, and that native 
TRPM7-like currents can be measured in this cell line15, 49. Potentially, the native hTRPM7 protein may form 
heteromeric channel complexes with recombinant mTRPM6 and thus contaminate our recordings. Indeed, we 
were able to elicit mTRPM7-like currents in untransfected HEK 293 cells (Fig. 2A,B). However, amplitudes of 
these endogenous currents were ~10-fold smaller than those in mTRPM6-expressing HEK 293 cells (Fig. 2D), 
suggesting that the currents measured in mTRPM6-transfected cells could not solely be attributed to the activity 
of endogenous hTRPM7.
Next, we asked whether mTRPM6 channel activity could be measured in the cells deficient in mTRPM7. To 
address this question, we used recently generated trophoblast stem (TS) cells derived from Trpm7 null mouse 
blastocysts37. As reported previously37, Trpm7-deficient TS cells completely lack native TRPM7-like currents 
(Fig. 2E,F). We found that transient overexpression of mTRPM6 resulted in whole-cell currents similar to 
mTRPM6 currents attained in HEK 293 cells. Hence, upon transient overexpression of recombinant protein, 
activity of homomeric mTRPM6 channel was measurable independently of the presence of endogenous TRPM7 
channels.
It has been reported27 that transient expression of human TRPM6 (hTRPM6) gives rise to a functional 
channel only if hTRPM6 cDNA is inserted into a specific expression vector, whereas the same cDNA clone 
placed in other expression plasmids did not yield functional hTRPM6 channels27. We could fully recapit-
ulate this finding (Supplementary Fig. S1). Thus, in analogy to the previous study27, transient transfection of 
the pCINeo-hTRPM6-IRES-GFP expression construct allowed us to detect hTRPM6 currents, well compara-
ble to mTRPM6 currents (Supplementary Fig. S1A). However, when investigating a HEK 293 T-REx cell line 
stably expressing hTRPM627, 50, we found that doxycycline-induced cells displayed currents undistinguish-
able from endogenous currents measured in uninduced cells (Supplementary Fig. S1B). Consequently, we 
asked whether functional expression of mTRPM6 cDNA would also be dependent on the expression system 
employed. We subcloned the mTRPM6 cDNA into the frequently used pcDNA3.1 vector38 and co-transfected 
this construct with a small amount of EGFP cDNA into HEK 293 cells. Patch-clamp analysis of EGFP-positive 
HEK 293 cells (Supplementary Fig. 2A) revealed currents very similar to those detected in cells transfected 
with pIRES2-mTRPM6-EGFP (Fig. 2B), suggesting that expression vectors are interchangeable for functional 
assessment of the mTRPM6 cDNA. In our follow-up experiments we used the pIRES2-mTRPM6-EGFP and 
pIRES2-mTRPM7-EGFP constructs.
Cation permeability of mTRPM6. TRPM7 channel is highly permeable to a range of divalent cations 
including Ca2+, Mg2+ and Zn2+ 15, 26. Therefore, we asked whether the cation permeation profile of mTRPM6 
differs from that of mTRPM7. In a first set of experiments, we assessed the permeation block of mTRPM7 cur-
rents by extracellular divalent cations, a well-known characteristic feature of TRPM715, 26. As expected, exposure 
of mTRPM7-expressing cells to a divalent cation-free (DVF) solution entailed large monovalent cation currents 
with a characteristic linear I-V relationship (Fig. 3A). These monovalent mTRPM7 currents were stable over the 
whole time of exposure. After wash-out, this characteristic response of mTRPM7 was fully reversed (Fig. 3A). 
We also noted that the endogenous TRPM7-like currents reliably recapitulated functional properties of recombi-
nant mTRPM7 (Fig. 3B). In contrast, mTRPM6-transfected cells only showed an initial TRPM7-like response to 
the application of DVF solution, characterized by prompt increases of outward and inward currents (red traces; 
Fig. 3C) followed by a fast, irreversible inactivation of mTRPM6 activity (green traces; Fig. 3C). Hence, unlike the 
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situation with mTRPM7, the removal of external divalent cations relieved the mTRPM6 channel from the divalent 
cation permeation block followed by the fast rundown of channel activity.
Divalent cation selectivity of TRPM7 has been determined by two means: (i) by shifts in the reversal potential 
of monovalent TRPM7 currents to more positive values after application of external solutions containing individ-
ual divalent cations15, 26, 29, and (ii) by changes of inward currents in cells exposed to external solutions containing 
only divalent cations15, 26, 29. Since a reliable assessment of the reversal potential of monovalent mTRPM6 currents 
was not possible (Fig. 3C), we used the second option as outlined in Fig. 4 and Fig. 5. We induced mTRPM7 and 
mTRPM6 currents using standard internal and external solutions containing 1 mM CaCl2 and 2 mM MgCl2. 
When currents were developed, cells were exposed to external solutions containing 10 mM of individual spe-
cific divalent cations (Zn2+ is poorly soluble above 10 mM at pH 7.0). To prevent Na+ from passing through 
the channels along with divalent cations, external monovalent cations were replaced by the non-permeant 
N-methyl-D-glucamine (NMDG). Similar to a previous study26, the exposure of mTRPM7-transfected cells to 
10 mM Zn2+ caused a ~3-fold increase in inward currents (Fig. 4A). The perfusion of cells with 10 mM Mg2+ or 
10 mM Ca2+ led to a modest, but statistically significant reduction of inward currents (Fig. 4B,C). Thus, in accord 
Figure 2. Assessment of mTRPM6 and mTRPM7 currents in HEK 293 and TS cells. (A) Whole-cell currents 
measured in mTRPM6 (red), mTRPM7-transfected (blue) and untransfected (black) HEK 293 cells. Current 
amplitudes (mean ± SEM) were acquired at −80 and +80 mV and plotted over time. (B) Magnification 
of mTRPM6 and endogenous TRPM7 currents shown in (A). (C) Representative current-voltage (I-V) 
relationships of currents (at 90 s) illustrated in (A). (D) Bar graphs of outward (Upper panel) and inward 
(Lower panel) currents (mean ± SEM) shown in (A) at 90 s. n, number of cells measured; n.s., not significant; 
**P < 0.01; ***P < 0.001 (ANOVA). (E,F) Functional expression of mTRPM6 in trophoblast stem (TS) cells. 
Trpm7-gene deficient TS cells were electroporated with mTRPM6 cDNA and examined as described in (A). (E) 
Whole-cell currents (mean ± SEM) measured in mTRPM6-transfected (red) and untransfected (black) TS cells. 
(F) I-V relationships of the currents (at 90 s) shown in (E). n, number of cells measured.
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with previous publications15, 26, 29, mTRPM7 showed a higher permeability for Zn2+ as compared to Mg2+ and 
Ca2+ under these experimental conditions. Corresponding experiments with mTRPM6 expressing cells showed 
that mTRPM6 is also highly permeable to Zn2+ as the application of Zn2+-based external solution caused a 
~2-fold increase of inward currents (Fig. 5A). Unlike mTRPM7, however, inward currents of mTRPM6 increased 
upon exposure of 10 mM Mg2+ (Fig. 5B) and were unaltered in the presence of 10 mM Ca2+ (Fig. 5C) indicating 
that the mTRPM6 channel is more permeable to Mg2+ as compared to Ca2+.
Finally, we tested whether mTRPM6 is also permeable to nonabundant trace cations such as Ba2+ 
(Supplementary Fig. S3). In line with a previous study26, we observed that the exposure of mTRPM7-transfected 
cells to 10 mM Ba2+ caused an increase in outward and inward currents (Supplementary Fig. S3A). In contrast, 
only outward currents of mTRPM6 were elevated in the presence of 10 mM Ba2+ (Supplementary Fig. S3B), 
suggesting that the mTRPM6 channel is less permeable to Ba2+ as compared to mTRPM7. To summarize, our 
experiments show that the divalent cation permeation profile of mTRPM6 is similar, but not identical to that of 
mTRPM7.
Figure 3. Assessment of mTRPM6 and mTRPM7 currents in a divalent cation-free (DVF) extracellular 
solution. Whole-cell currents measured in mTRPM7-transfected (A), untransfected (B) and mTRPM6-
transfected HEK 293 cells (C). Left panels: Current amplitudes (mean ± SEM) were measured at −80 and 
+80 mV and plotted over time. Currents were induced using the standard [Mg2+]i-free intracellular solution 
and the standard external solution. When currents were fully activated, cells were perfused with the DVF 
solution as indicated by the black bars. Right panels: Representative I-V relationships obtained from individual 
ramps before (blue), during (red and green) and after (violet) DVF application as indicated in the Left panels by 
coloured data points. n, number of cells measured.
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High sensitivity of mTRPM6 currents to intracellular Mg2+. A remarkable feature of the TRPM7 
channel is its high sensitivity to physiological levels of cytosolic Mg2+ ([Mg2+]i) and Mg·ATP ([Mg·ATP]i)15, 26, 27, 51. 
Therefore, we compared the effects of [Mg2+]i and [Mg·ATP]i on mTRPM6 and mTRPM7 currents using solu-
tions containing various concentrations of free Mg2+ and Mg·ATP. In initial experiments, we studied mTRPM7 
currents in the presence of 1 µM free [Mg2+]i (Fig. 6A,F). In line with previous reports15, 26, 27, 51, we observed 
no inhibitory effect of 1 µM free [Mg2+]i on mTRPM7 (Fig. 6A,F) and only a moderate suppression of endog-
enous TRPM7-like currents (Fig. 6B,F). Surprisingly, we found that currents in mTRPM6-transfected cells 
did not develop at all in the presence of 1 µM [Mg2+]i (Fig. 6C,F). Consistently, mTRPM6 overexpressed in 
mTRPM7-deficient TS cells was also inactive in the presence of 1 µM free [Mg2+]i (Supplementary Fig. S2B). 
Furthermore, even when we applied a nominally [Mg2+]i-free intracellular solution (Fig. 6D,F), cells transfected 
with mTRPM6 cDNA failed to develop any currents indicating that mere traces of free Mg2+ are sufficient to 
block mTRPM6. Such unexpected sensitivity of mTRPM6 to Mg2+ prompted us to examine the influence of 1 µM 
Figure 4. Examining of divalent cations permeability of mTRPM7. (A) Left panel: Whole-cell currents were 
recorded in mTRPM7-transfected HEK 293 cells using the standard [Mg2+]i-free internal solution and standard 
external solution. When currents started to develop, cells were subsequently exposed to the external solution 
containing 10 mM Zn2+ as indicated by a bar. Data are shown as I/Imax ± SEM (Imax value was obtained in 
a ramp before application of 10 mM Zn2+). Middle panel: Representative I-V relationships of inward currents 
obtained before (blue) and during (red) application of 10 mM Zn2+ as indicated in the Left panel. Right 
panel: Bar graphs of inward currents (−80 mV, mean I/Imax ± SEM) obtained before (blue) and during (red) 
application of 10 mM Zn2+ as indicated in the Left panel. (B,C) Changes in the inward mTRPM7 currents by 
exposure of cells to external solutions containing 10 mM Mg2+ (B) and 10 mM Ca2+ (C). Measurements were 
performed similarly to (A). n, number of cells measured; *P < 0.05; ***P < 0.001 (two-tailed t-test).
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[Mg2+]i on currents in HEK 293 cells transfected with pCINeo-hTRPM6-IRES-GFP (Supplementary Fig. S1A). 
We found that hTRPM6 currents were not affected by 1 µM [Mg2+]i (Supplementary Fig. S1A), indicating that the 
high sensitivity of mTRPM6 to cytosolic Mg2+ can be attributed to the mTRPM6 channel itself rather than to the 
experimental conditions used. Since known Mg2+ chelators, such as EDTA or EGTA, do not allow to reliably pre-
pare a saline solution containing [Mg2+]i in the nM range, we did not attempt to obtain concentration-response 
data for mTRPM6 currents.
It has been suggested that the catalytic activity of the TRPM7 kinase domain regulates the sensitivity of 
the TRPM7 channel to [Mg2+]i and [Mg·ATP]i51. Therefore, we asked whether the kinase activity of mTRPM6 
might be responsible for the high sensitivity of mTRPM6 to [Mg2+]i. To address this question, we examined cells 
transiently expressing the ‘kinase-dead’ mTRPM6-K1810R variant (Fig. 1B) and found that mTRPM6-K1810R 
remained inactive in the presence of 1 µM [Mg2+]i, but could be induced using the standard [Mg2+]i-free 
Figure 5. Determination of divalent cations permeability of mTRPM6. Measurements were performed 
similarly to Fig. 4. (A) Left panel: Whole-cell currents were recorded in mTRPM6-transfected HEK 293 cells 
using the standard [Mg2+]i-free internal solution and standard external saline. When currents started to 
develop, the cells were exposed to an external solution containing 10 mM Zn2+ as indicated by a bar. Data 
are shown as I/Imax ± SEM (Imax value was obtained in a ramp before application of 10 mM Zn2+). Middle 
panel: Representative I-V relationships of inward currents obtained before (blue) and during (red) application 
of 10 mM Zn2+ as indicated in the Left panel. Right panel: Bar graphs of inward currents (−80 mV, mean I/
Imax ± SEM) obtained before (blue) and during (red) application of 10 mM Zn2+ as indicated in the Left 
panels. (B,C) Changes in the inward mTRPM6 currents by exposure of cells to external solutions containing 
either 10 mM Mg2+ (B) or 10 mM Ca2+ (C). n, number of cells measured; n.s., not significant; **P < 0.01; 
***P < 0.001 (two-tailed t-test).
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intracellular pipette solution (Fig. 6E,F). We conclude that the kinase activity of mTRPM6 is not involved in the 
strong inhibitory effect of [Mg2+]i on the mTRPM6 channel activity.
In a physiological saline solution, the apparent Kd of Mg·ATP is 50 ± 10 µM52 implying that cytosolic Mg·ATP 
will always co-exist with a certain amount of free Mg2+ sufficient to block mTRPM6 regardless of the actual con-
tent of Mg·ATP. To test this assumption, we compared the effects of a relatively low concentration of [Mg·ATP]i 
(210 µM) on mTRPM7 and mTRPM6. We observed that mTRPM7 currents were partially inhibited by Mg·ATP 
(Fig. 7A,E). Interestingly, endogenous TRPM7-like currents were only modestly affected under these con-
ditions (Fig. 7B,E). As expected, 210 µM [Mg·ATP]i strongly suppressed currents in wild-type mTRPM6 and 
mTRPM6-K1810R transfected cells (Fig. 7C–E). Hence, mTRPM6 displays an extraordinarily high sensitivity to 
cytosolic Mg2+ independent of the catalytic activity of its kinase domain.
Figure 6. Effects of cytosolic Mg2+ on mTRPM6 and mTRPM7 currents. Whole-cell currents (mean ± SEM) 
measured in mTRPM7-transfected HEK 293 cells (A), untransfected HEK 293 cells (B), or cells transfected 
either by wildtype mTRPM6 (C,D) or ‘kinase-dead’ mTRPM6-K1810R variant (E). In (A–C and E) cells 
were perfused either with a standard [Mg2+]i-free intracellular solution or with a solution containing 1 µM 
free [Mg2+]i. In (D) measurements were performed with mTRPM6-transfected cells as in (C) except that a 
nominally [Mg2+]i-free solution (n.f.) was used. (F) Bar graphs of outward currents (−80 mV) shown in (A–E). 
Current amplitudes (mean ± SEM) were extracted at time intervals when the currents were maximally induced: 
at 200 s for mTRPM7 (blue) and untransfected cells (black), 50 s for wildtype mTRPM6 (red and brown), 80 s for 
mTRPM6-K1810R (green). n, number of cells measured; n.s., not significant; *P < 0.05; **P < 0.01 (two-tailed 
t-test).
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Functional characterization of heteromeric mTRPM6/7 channel complexes. Our experiments 
with recombinant mTRPM6 suggest that homomeric mTRPM6 channels, if formed in the cell, will most likely be 
inactive in the presence of physiological concentrations of cytosolic Mg2+ (Fig. 6), which are estimated to be in the 
range of 0.3–1 mM53, 54. Previously, we suggested38, 39 that the native TRPM6 protein primarily exists as a subunit 
of heteromeric channel complexes formed by TRPM6 and TRPM7 (TRPM6/7). Consequently, we asked whether 
such a paradoxical Mg2+ sensitivity of mTRPM6 would look different in mTRPM6/7 complexes. To address this 
question, we co-transfected mTRPM6 and mTRPM7 expression constructs in HEK 293 cells. Western blot anal-
ysis of cell lysates revealed that co-expression of mTRPM6 had no effect on the expression levels of mTRPM7 
(Supplementary Fig. S4). Next, we used an immunoprecipitation approach to show that mTRPM6 is able to asso-
ciate with mTRPM7. mTRPM7 fused to a myc tag (mTRPM7-myc) was expressed in HEK 293 cells either alone 
or co-expressed with mTRPM7, mTRPM6 and mTRPM5 containing a YFP tag (mTRPM7-YFP, mTRPM6-YFP 
and mTRPM5-YFP, respectively). mTRPM7-myc was solubilized and immunoprecipitated using an anti-myc 
antibody. Both cell lysates and immunoprecipitates were subjected to SDS-gel electrophoresis and subsequent 
immunoblotted with an anti-GFP antibody (cross-reacting with YFP) or anti-myc antibody (Supplementary 
Figure 7. Effects of cytosolic Mg·ATP on mTRPM6 and mTRPM7 currents. (A) Whole-cell currents 
(mean ± SEM) measured in mTRPM7-transfected HEK 293 cells (A), untransfected cells (B), or cells 
transfected either by wildtype mTRPM6 (C) or mTRPM6-K1810R variant (D). Cells were perfused either with 
the standard [Mg2+]i-free intracellular solution or with a solution containing 210 µM Mg·ATP (10 µM free 
Mg2+). (E) Bar graphs of outward currents (−80 mV) shown in (A–D). Current amplitudes (mean ± SEM) were 
extracted at time intervals when the currents were maximally induced by the Mg2+-free intracellular solution 
as follows: at 200 s for mTRPM7 (blue) and untransfected cells (black), 50 s for wildtype mTRPM6 (red) and 
mTRPM6-K1810R (green). n, number of cells measured; n.s., not significant; **P < 0.01; ***P < 0.001 (two-
tailed t-test).
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Fig. S5). As expected, we detected mTRPM7-myc in the cell lysates and immunoprecipitates (Supplementary 
Fig. S5). In addition, mTRPM7-myc immunoprecipitates contained mTRPM7-YFP and mTRPM6-YFP, but not a 
more distantly related channel, mTRPM5-YFP (Supplementary Fig. S5). Hence, in line with our previous findings 
with hTRPM638, 39, mTRPM6 can assemble with mTRPM7 in heteromeric channel complexes.
Next, we performed patch-clamp experiments with HEK 293 cells co-transfected with mTRPM6 and 
mTRPM7 cDNA constructs. In initial experiments, we assessed the currents induced by standard [Mg2+]i-free 
internal solution (Fig. 8A). We found that cells co-transfected with 1 µg mTRPM6 and 1 µg mTRPM7 cDNA 
constructs displayed mTRPM7-like currents substantially larger than cells transfected with 2 µg mTRPM7 cDNA 
alone (Fig. 8A). In addition, we noted that all cells transfected with mTRPM6/7 cDNAs exhibited large currents 
already at break-in (Fig. 8B). I-V relationships of these pre-activated currents (Fig. 8B) were indistinguishable 
Figure 8. Assessment of mTRPM6/7 currents. (A) Left panel: Whole-cell currents measured in mTRPM7- 
(blue) and mTRPM6/7-transfected (grey) HEK 293 cells using the standard [Mg2+]i-free internal solution and 
standard external solution. Current amplitudes (mean ± SEM) were acquired at −80 and +80 mV and plotted 
over time. Middle panel: Representative I-V relationships (at 200 s) of currents shown in the Left panel. Right 
panel: Bar graphs of outward currents (+80 mV) shown in the Left panel. (B) A magnification of currents 
illustrated in (A). Left panel: Outward current amplitudes (at +80 mV) acquired from individual cells with the 
corresponding means (dots). Middle panel: Representative I-V relationships of currents (at 2 s) shown in the Left 
panel. Right panel: Bar graphs of outward currents (mean ± SEM) at +80 mV in the Left panel. n, number of cells 
measured; **P < 0.01; ***P < 0.001 (two-tailed t-test). (C) Dose-dependent inhibition of currents (+80 mV, 
200 s) by [Mg2+]i. Measurements (n = 10–12 cells per concentration) were performed as in (A). n, number of 
cells measured for individual [Mg2+]i tested.
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from those of fully developed currents (Fig. 8A). In contrast, all solely mTRPM7 expressing cells displayed very 
small currents after break-in (Fig. 8B). Further analyses revealed that amplitudes of pre-activated currents of 
mTRPM6/7 were ~10-fold larger than corresponding values obtained with mTRPM7 expression (Fig. 8B) and 
were comparable with fully activated currents (at 90 s) of mTRPM6 homomers (Fig. 2B). Of note, such constitu-
tive channel activity was not observed in experiments with untransfected HEK 293 cells (Fig. 2B) or in cells trans-
fected by mTRPM6 alone (Fig. 2A). These findings indicate that in resting cells heteromeric mTRPM6/7 channels 
were active prior to manipulation of intracellular [Mg2+]i and [Mg·ATP]i via the patch pipette. Consequently, 
we asked whether such high constitutive activity of mTRPM6/7 can be attributed to an increased expression of 
mTRPM6 or mTRPM7 protein in the plasma membranes of cells co-transfected with both constructs as com-
pared to cells expressing only mTRPM6 or mTRPM7. To this end, we isolated the plasma membrane proteins 
from cells transfected with mTRPM6 or mTRPM7 and from cells co-transfected with mTRPM6 and mTRPM7 
cDNA (Supplementary Fig. S6). Western blot analysis revealed that the plasma membrane levels of mTRPM6 
and mTRPM7 protein in co-transfected cells were reduced as compared to cells expressing only mTRPM6 or 
mTRPM7 (Supplementary Fig. S6). Hence, the high channel activity of mTRPM6/7 is unlikely caused by an 
increased expression of heteromeric channels in the plasma membrane, but represents a qualitative hallmark of 
mTRPM6/7.
Next, we examined the concentration-dependent suppression of currents by [Mg2+]i (Fig. 8C, Supplementary 
Table S1). Cells expressing mTRPM6/7 exhibited larger current amplitudes over the whole range of [Mg2+]i exam-
ined (P ≤ 0.0001, F-test). Compared to mTRPM7, we noted only a modest, but statistically significant rightward 
shift of the concentration-response curve of mTRPM6/7 currents. Thus, the calculated IC50 value for mTRPM7 
currents was 1.29 mM. Currents in mTRPM6/7 expressing cells were inhibited by [Mg2+]i with an IC50 value of 
1.55 mM (P ≤ 0.001, F-test). These results suggest that mTRPM7 in mTRPM6/7 complexes offsets the exquisite 
Mg2+ sensitivity of mTRPM6 to physiological levels of cytosolic Mg2+.
Next, we asked whether mTRPM6/7 would be active in the presence of Mg·ATP. Physiological concentrations 
of [Mg·ATP]i vary between 2–7 mM in most mammalian cells53, 54. First, we studied the effects of relatively high 
levels of Mg·ATP (Fig. 9A). We found that 9 mM [Mg·ATP]i entailed nearly complete suppression of mTRPM7 
channel activity. In contrast, mTRPM6/7 currents were only modestly inhibited by 9 mM [Mg·ATP]i (Fig. 9A). 
Concordant with experiments shown in Fig. 8B, we observed ~10-fold higher channel activity in mTRPM6/7 
expressing cells immediately after break-in (Fig. 9B). Next, we compared the concentration-dependent sup-
pression of mTRPM6/7 and mTRPM7 currents by [Mg·ATP]i (because of experimental limitations, effects of 
[Mg·ATP]i higher than 10 mM could not be reliably examined). [Mg·ATP]i suppressed mTRPM7 currents with an 
IC50 value of 2.93 mM (Fig. 9C, Supplementary Table S2). In contrast, mTRPM6/7 complexes were characterized 
by a remarkably low sensitivity to [Mg·ATP]i at all concentrations examined (P ≤ 0.0001, F-test). Such a weak 
effect of [Mg·ATP]i on mTRPM6/7 currents did not allow for a reliable calculation of an IC50 value. Nevertheless, 
the concentration-response data indicate that more than 15 mM [Mg·ATP]i are required to reduce mTRPM6/7 
currents by ~50% (Fig. 9C), suggesting that, in stark contrast to mTRPM7, physiological levels of [Mg·ATP]i will 
exert only a minor (if any) inhibitory effect on mTRPM6/7 currents.
It has been proposed that the catalytic activity of the hTRPM6 kinase domain regulates the sensitivity of 
the hTRPM6/7 channels to [Mg·ATP]i27. Therefore, we investigated whether the kinase-inactivating K1810R 
mutation in mTRPM6 would shift the [Mg·ATP]i sensitivity of the mTRPM6/7 channels into the mTRPM7-like 
range. We examined cells transiently expressing mTRPM6-K1810R and wildtype mTRPM7 and found that 
mTRPM6-K1810R behaved similarly to wildtype mTRPM6. Specifically, we found that the standard Mg2+-free 
internal solution induced mTRPM6-K1810R/7 currents (Supplementary Fig. S7) comparable to values displayed 
by the wildtype mTRPM6/7 channels (Fig. 8A) and that the ‘kinase-dead’ mutation did not offset the low sensitiv-
ity of heteromeric channels to 9 mM [Mg·ATP]i (Supplementary Fig. S7). We conclude that the catalytic activity 
of the mTRPM6 kinase is unlikely to play a major role in this regulatory mechanism.
Finally, we studied whether mTRPM6 and mTRPM6/7 respond differentially to small synthetic molecules 
acting as activators or inhibitors of the mTRPM7 channel55. We first examined the effect of NS8593, a potent 
mTRPM7 inhibitor49, on mTRPM6 currents (Supplementary Fig. S8A). In this experiment, we induced mTRPM6 
currents using a Mg2+-free pipette solution and externally applied 10 µM NS8593 when mTRPM6 currents 
were fully developed. We noted that NS8593 caused a rapid irreversible inhibition of mTRPM6 (Supplementary 
Fig. S8A). Next, we assessed effects of naltriben, a potent agonist of mTRPM7 channel56. In these experiments, 
we used intracellular solutions containing 2 mM [Mg2+]i for mTRPM7, whereas mTRPM6 currents were eval-
uated in the presence of a [Mg2+]i-free solution or saline containing 1 µM fee [Mg2+]i. As expected, the exter-
nal application of 50 µM naltriben led to a fast stimulation of mTRPM7 currents (Supplementary Fig. S8B). 
Unlike mTRPM7, mTRPM6 did not respond to 50 µM naltriben, neither in the presence of 1 µM [Mg2+]i nor 
in Mg2+-free conditions (Supplementary Fig. S8C). It has been reported that 2-aminoethyl diphenylborinate 
(2-APB) acts as a positive modulator of hTRPM6 and an inhibitor of hTRPM727, 43. In our experimental set-
tings, 200 µM 2-APB reversibly blocked mTRPM7 currents (Supplementary Fig. S9A). In contrast, 200 µM 2-APB 
potentiated mTRPM6 currents (Supplementary Fig. S9B). Hence, mTRPM6 displays distinct responses to naltri-
ben and 2-APB. Consequently, we asked how these compounds affect mTRPM6/7 currents. We observed that nal-
triben (50 µM) could modestly potentiate mTRPM6/7 currents, but these changes were not statistically significant 
(Supplementary Fig. S8D). 200 µM 2-APB triggered a moderate, slow and irreversible rundown of mTRPM6/7 
currents (Supplementary Fig. S9C). Taken together, our study offers a set of endogenous and exogenous agents 
enabling to distinguish mTRPM6, mTRPM7 and mTRPM6/7 currents.
Discussion
Here we employed a newly cloned mTRPM6 cDNA to provide further evidence in support of the previously 
suggested concept that native TRPM6 functionally interacts with TRPM7 to maintain transcellular Mg2+ 
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transport37–39. We show that mTRPM6 and mTRPM7 differentially contribute to regulatory characteristics of 
heteromeric mTRPM6/7 channel complexes: mTRPM7 is able to offset the very high sensitivity of mTRPM6 to 
cytosolic Mg2+ to physiologically relevant concentrations, whereas mTRPM6 relieves mTRPM7 from inhibition 
by Mg·ATP. Consequently, in contrast to mTRPM7, the activity of mTRPM6/7 channels will hardly be affected by 
physiological intracellular concentrations of Mg2+ and Mg·ATP. Such a functional fingerprint is most likely not 
critical for metabolic processes in resting cells, but this mechanism appears to be an indispensable prerequisite 
Figure 9. Sensitivity of mTRPM6/7 currents to cytosolic Mg·ATP. (A) Left panel: Whole-cell currents measured 
in mTRPM7 (blue) and mTRPM6/7 (grey) transfected HEK 293 cells using internal solutions containing 9 mM 
[Mg·ATP]i and 250 µM free [Mg2+]i (open dots) or only 250 µM free [Mg2+]i (closed dots). Current amplitudes 
(mean ± SEM) were acquired at −80 and +80 mV and plotted over time. Middle panel: Representative I-V 
relationships (at 200 s) of currents shown in the Left panel. Right panel: Bar graphs of outward currents 
(−80 mV) shown in the Left panel. (B) Magnification of currents illustrated in (A). Left panel: Outward current 
amplitudes (at +80 mV) acquired from individual cells with the corresponding means (dots). Middle panel: 
Representative I-V relationships of currents (at 2 s) shown in the Left panel. Right panel: Bar graphs of outward 
currents (mean ± SEM) at +80 mV in the Left panel. n, number of cells measured; **P < 0.01; ***P < 0.001 
(two-tailed t-test). (C) Dose-dependent inhibition of mTRPM7 (blue) and mTRPM6/7 (grey) currents 
(+80 mV, 200 s) by [Mg·ATP]i (250 µM free [Mg2+]i). Measurements (n = 9–12 cells per concentration) were 
performed as in (A).
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for efficient transcellular Mg2+ transport in placental and intestinal epithelial cells i.e. when a high and constant 
uptake of extracellular Mg2+ should be uncoupled from the cellular metabolism of Mg2+ and Mg·ATP.
TRPM6 is inevitably co-expressed with the ubiquitously present TRPM7 and the mechanism of the 
non-redundant role of TRPM6 for organismal Mg2+ balance is subject to considerable debate. Previously, our 
group extensively studied recombinant expression of hTRPM6 in HEK 293 cells and in Xenopus oocytes38, 39. 
Regardless of the experimental system and plasmid backbone used, we observed that hTRPM6 homomultim-
ers are retained in intracellular membrane compartments. However, co-expression of hTRPM6 and mTRPM7 
resulted in co-trafficking of TRPM6/7 channels to the cell surface38–40. Current amplitudes of TRPM6/7 
complexes were found to be higher than those of TRPM7 homomers38, 39. The assembly of recombinant het-
eromeric TRPM6/7 channel complexes was demonstrated by fluorescence resonance energy transfer (FRET) 
and co-immunoprecipitation approaches as well as by functional analysis of channel subunits carrying a 
dominant-negative point mutation in the pore-forming segment38–40. More recently, we investigated placental 
trophoblast stem (TS) cells isolated from gene-modified mice37. We observed that a disruption of native mTRPM6 
resulted in a reduction of current amplitudes, whereas deletion of mTRPM7 caused complete ablation of endog-
enous currents. Remarkably, the currents in mTRPM6-deficient TS cells were considerably more sensitive to 
intracellular Mg·ATP37. These findings are consistent with a recent study of Zhang et al.57 elucidating the contri-
bution of hTRPM6 and hTRPM7 to endogenous currents in human neuroblastoma SHEP-21N cells, and with 
work of Ryazanova et al. examining native currents in mouse embryonic stem (ES) cells expressing mTRPM6 and 
mTRPM75. The latter reports also showed that genetic ablation of mTRPM7 led to full suppression of TRPM7-like 
currents. Hence, the functional analysis of native currents entertains the notion that native TRPM6 functions as 
a subunit of TRPM6/7 complexes where it increases current amplitudes and relieves TRPM7 from inhibition by 
[Mg·ATP]i.
However, it should not go unnoticed that other researchers claimed that hTRPM6 can function inde-
pendently of TRPM742–44. The latter proposition is based on the finding that transient transfection of 
pCINeo-hTRPM6-IRES-GFP expression constructs (but not other expression vectors27) allows to detect channel 
activity of hTRPM6 homomultimers. Interestingly, experiments with pCINeo-hTRPM6-IRES-GFP yielded remark-
ably different results concerning the sensitivity of hTRPM6 to [Mg2+]i and [Mg·ATP]i. Thus, one group reported 
that hTRPM6 is suppressed by [Mg2+]i and [Mg·ATP]i with IC50 values of 510 µM and 1.3 mM, respectively42, 44. 
In contrast, another laboratory observed that pCINeo-hTRPM6-IRES-GFP evoked currents that were completely 
insensitive to 3–9 mM [Mg·ATP]i, whereas [Mg2+]i efficiently blocked hTRPM6 currents with a physiologically 
irrelevant IC50 of 29 µM27. The reasons for such discrepancies still remain unclear. In particular, there is no sensi-
ble argument as to why only one specific expression plasmid should allow for functional expression of hTRPM6.
Since the functional characteristics of heterologously expressed hTRPM6 are surrounded by considerable con-
troversy, we focussed on a newly isolated murine TRPM6 clone. We noted that recombinant mTRPM6 homomul-
timers could be functionally expressed irrespective of the vector backbone used. Although such an overexpression 
system does not fully recapitulate the properties of native mTRPM6 (e.g. endogenous mTRPM6 at rather low 
protein levels is active only in the presence of mTRPM737), this in vitro model may be instrumental in dissect-
ing functional hallmarks of the kinase and channel activity of mTRPM6 upon co-expression with recombinant 
mTRPM7. We noted that overexpression of mTRPM6 in HEK 293 cells yielded currents significantly (~3-fold) 
smaller than mTRPM7 currents. In contrast to mTRPM7, mTRPM6 currents rapidly inactivated, especially when 
the mTRPM6 expressing cells were exposed to monovalent cation-based external solutions. We also noted that 
the mTRPM6 channel is more selective for Zn2+ as compared to Mg2+, Ca2+ and Ba2+, resembling the ion perme-
ation profile of mTRPM7. Surprisingly, the mTRPM6 channel was found to be highly sensitive to cytosolic Mg2+: 
mTRPM6 was inactive even in the presence of a nominally Mg2+-free intracellular solution. The catalytic activity 
of the mTRPM6 kinase does not appear to play a role in the channel’s high sensitivity to [Mg2+]i. In this context, 
our findings are in accord with results of Zhang et al. showing supressed hTRPM6 currents in the presence of 
non-physiologically low concentrations of [Mg2+]i (IC50 of 29 µM)27. Therefore, mTRPM6 as well as hTRPM6 
homomers, if formed, will be inactive in the presence of physiological levels of cytosolic Mg2+ or [Mg·ATP]i.
Finally, we examined how mTRPM6 may modulate the response of mTRPM7 to [Mg2+]i and [Mg·ATP]i. We 
noted that cells co-transfected with mTRPM6 and mTRPM7 displayed currents amplitudes significantly larger 
than cells only harbouring recombinant mTRPM7, mimicking the situation in TS cells37. Of note, mTRPM6/7 
channels displayed high channel activity immediately after break-in of the patch, suggesting that mTRPM6/7 
complexes are constitutively active in the presence of steady-state cytosolic concentrations of Mg2+ and Mg·ATP. 
In line with this concept, we observed that, contrary to mTRPM7, mTRPM6/7 currents were only slightly inhib-
ited by physiological levels of [Mg·ATP]i (3–9 mM) and were significantly more active in the presence of phys-
iological [Mg2+]i levels (0.5–1 mM). These findings are concordant with the study of Zhang et al. reporting that 
hTRPM6/7 heteromers are not sensitive to 9 mM [Mg·ATP]i27 and additionally with our assessment of native 
currents in TRPM6- vs TRPM7-deficient TS cells37. Moreover, we found that the catalytic activity of the mTRPM6 
kinase does not contribute to the low sensitivity of the mTRPM6/7 channels to [Mg·ATP]i. Lastly, mTRPM6/7 dis-
played differential responses to small organic compounds such as naltriben and 2-APB as compared to mTRPM6 
or mTRPM7.
To summarize, our findings indicate that mTRPM6 and mTRPM7 contribute differentially to key functional 
characteristics of mTRPM6/7 complexes thereby functionally defining a new type of channel that remains active 
in the presence of physiological concentrations of [Mg2+]i and [Mg·ATP]i. Consequently, mTRPM6/7 channels 
will be able to maintain a constant supply of Mg2+ for the organism regardless of the actual metabolic state of 
epithelial cells. In contrast, the channel activity of mTRPM7 homomers is tightly controlled by cytosolic levels 
of [Mg2+]i and [Mg·ATP]i and, thus, closely linked to cellular metabolism. Such a mechanistic model provides a 
plausible answer for the hitherto open question as to why in transporting epithelia TRPM6 function cannot be 
replaced by other ion channels including TRPM7.
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Methods
Molecular biology, in silico analysis and cell culture. In the course of NCBI GenBank data min-
ing, a predicted mRNA sequence of Mus musculus Trpm6 gene was identified (NM_153417.1) and was 
therefore used for cloning of a full-length Trpm6 cDNA. TRIzol reagent (Thermo Fisher Scientific) was used 
for extraction of total RNA from the whole lung of C57BL/J mice and SuperScript II reverse transcriptase 
(Thermo Fisher Scientific) for first strand synthesis. The Expand High Fidelity polymerase enzyme system 
(Roche) was used for PCR amplification of different overlapping segments of the predicted TRPM6 ORF. We 
used the following primer pairs: mM6for1 5′-GAGAATGCAGGTCAAGAAGCAATC-3′ and mM6rev3 
5′-TGCCCACAGTCCCATCAT-3′ with PCR settings: 94 °C 3′, 94 °C 30″, 55 °C 30″, 72 °C 1′, 35 cycles, 72 °C 5′ 
(PCR product 752 bp encompassing exons 1–7 of Trpm6); mM6for2 5′-TGCCCTAAAAGCCCATTCCTCTAA-3′ 
and mM6rev4 5′-CGTCCCCCTCTTCCTGGTCCTGT-3′ with PCR settings: 94 °C 3′, 94 °C 30″, 58 °C 
30″, 72 °C 3′, 35 cycles, 72 °C 5′ (PCR product 2873 bp corresponding to exons 2–24 of Trpm6); mM6for3 
5′-ATGGCGCCTGGCTCGTGACA-3′ and mM6rev2 5′-ACCACCGTCTTCCTTCATCATCTTTTT-3′ with 
PCR settings: 94 °C 3′, 94 °C 30″, 58 °C 30″, 72 °C 4′, 35 cycles, 72 °C 5′ (PCR product 3077 bp comprising sequence 
of exons 22–39 of Trpm6). The obtained PCR products were inserted into pcDNA3.1 vector by a TOPO-cloning 
approach (pcDNA3.1/V5-His TA-TOPO kit, Thermo Fisher Scientific) and confirmed by sequencing (Eurofins 
Genomics, Ebersberg, Germany). Next, the full-length Trpm6 cDNA (NCBI accession KX375810) was gener-
ated by in-frame subcloning of the latter cDNA fragments either in pcDNA3.1 or in pIRES2-EGFP (Clontech) 
expression vectors using standard molecular biological techniques. Translation in silico (DNASTAR Lasergene 
software) of the cloned TRPM6 cDNA produced a 2028-aa ORF that matched to the predicted ORF sequence in 
NM_153417.1. 3D model of the TRPM6 kinase domain structure were generated as reported previously29, 39 using 
MODELLER (modbase.compbio.ucsf.edu/modweb) and UCSF Chimera (www.cgl.ucsf.edu/chimera).
K1810R and T1730A point mutations in mTRPM6 cDNA (both in pIRES2-EGFP vector) were introduced 
by site-directed mutagenesis (QuikChange, Stratagene). To generate mTRPM6 with a C-terminal myc tag in the 
pcDNA3.1/V5-His TA-TOPO vector (mTRPM6-myc) and with a C-terminal yellow fluorescent protein (YFP) tag 
in pcDNA3.1/V5-His TA-TOPO vector (mTRPM6-YFP), a STOP codon in the mTRPM6 cDNA was replaced by 
a SalI restriction site through site-directed mutagenesis followed by in-frame sub-cloning of myc or YFP coding 
sequence as reported previously26, 43. All generated mTRPM6 cDNA variants were verified by sequencing.
mTRPM7 (in pIRES2-EGFP vector), mTRPM7-myc (in pcDNA3.1/V5-His TA-TOPO vector) and 
mTRPM7-myc (in pcDNA3.1/V5-His TA-TOPO) were reported previously29, 38, 58. mTRPM5-YFP (in 
pcDNA3.1/V5-His TA-TOPO) was described earlier59, 60. Likewise, the hTRPM6 expression construct 
(pCINeo-hTRPM6-IRES-GFP) has been reported before27, 42.
Human embryonic kidney (HEK) 293 cells were grown at 37 °C and 5% CO2 in Eagle’s minimum essential 
medium (MEM, Sigma Aldrich) supplemented with 10% fetal bovine serum (FBS, Thermo Fisher Scientific), 
100 U/ml penicillin and 100 µg/ml streptomycin (P/S, Sigma-Aldrich). Cells were transiently transfected by 2 µg 
expression constructs using Lipofectamine 2000 reagent (Thermo Fisher Scientific). In some experiments, 1 µg of 
mTRPM6 and 1 µg mTRPM7 cDNA constructs were co-transfected in HEK 293 cells. Patch-clamp experiments 
were performed 20–24 h after transfection. Successfully transfected cells were identified by their green fluores-
cence when illuminated at 480 nm.
The HEK-293 T-REx cell line stably expressing hTRPM6 was cultured as reported previously27, 50. hTRPM6 
overexpression was induced by adding 1 µg/ml doxycycline (Thermo Fisher Scientific) to the growth medium. 
Patch-clamp experiments were performed 20–24 h after induction.
Transient expression of mTRPM6 in Trpm7-deficient trophoblasts stem (TS) cells. Trpm7-gene 
deficient TS cells were generated as described before37. TS cells were incubated in a humidified cell culture incu-
bator (Heraeus, Thermo Fisher Scientific) at 37 °C and 5% CO2 in RPMI 1640 medium (Thermo Fisher Scientific) 
supplemented with 20% fetal bovine serum (ES type, Thermo Fisher Scientific), 1 mM sodium pyruvate (cell 
culture type, Sigma-Aldrich), 100 µM β-mercaptoethanol (Sigma-Aldrich), 50 µg/ml streptomycin and 50 U/
ml penicillin (Thermo Fisher Scientific), 1.0 µg/ml heparin (cell culture type, Sigma-Aldrich), 25 ng/ml human 
recombinant FGF4 (R&D systems), 5 ng/ml human recombinant TGF-β1 (R&D systems), 10 ng/ml recombinant 
activin A (R&D systems) and an additional 10 mM MgCl2. For transient expression of mTRPM6, 1 × 105 TS cells 
were electroporated with 2 µg cDNA by applying two voltage pulses (1000 V, 30 ms) using Neon Transfection 
System (Thermo Fisher Scientific). The TS cells were studied 24 h after electroporation.
Generation of (p)T1730 mTRPM6-specific antibody and Western blot analysis. To generate 
a polyclonal (p)T1730 mTRPM6-specific antibody, rabbits were immunized with a phosphorylated peptide 
AcNH-RLSQ(p)TIPFTPIQC-CONH2 coupled via its C-terminal cysteine residue to keyhole limpet hema-
cyanin (Eurogentec, Belgium). The generated serum was subjected to two rounds of peptide affinity chroma-
tography. First, a fraction of antibody was purified using the phosphorylated peptide. Second, the isolated 
antibody was followed by an additional round of chromatography using a non-phosphorylated variant of the 
peptide (AcNH-RLSQTIPFTPIQC-CONH2) in order to deplete a fraction of antibody with cross-reactivity to 
a non-phosphorylated mTRPM6 protein. The final fraction of anti-(p)T1730 mTRPM6 antibody was aliquoted 
and stored at −80 °C.
To assess the mTRPM6 kinase activity, the anti-(p)T1730 mTRPM6 antibody was used to probe cell lysates 
obtained from HEK 293 transiently transfected with mTRPM6 cDNA variants. In some experiments (Fig. 1D) 
transfected cells were cultured for 12 h in the presence of TG100–115 (Absource Diagnostic GmbH). The lysis 
buffer (Pierce IP Lysis Buffer, Pierce) contained protease inhibitor and phosphatase inhibitor cocktails (Biotool). 
Aliquots of the cell lysates were mixed (1:1) with 2x Laemmli buffer, heated at 70 °C for 10 min and cooled on 
ice. The samples were separated by SDS-PAGE (6% acrylamide/bis-acrylamide, Carl Roth) and electroblotted 
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on nitrocellulose membranes (GE Healthcare Life Science). After blocking with 5% (w/v) non-fat dry milk in 
Tris-buffered saline with 0.1% Tween 20 (TBST), the membranes were probed by (p)T1730 mTRPM6-specific 
antibody (1 µg/ml in TBST with 5% (w/v) BSA), followed by washing in TBST, incubation with a horseradish 
peroxidase-coupled anti-rabbit lgG (Cell Signaling Technology; 1:1000 in TBST with 5% (w/v) non-fat dry milk) 
and washing again in TBST. Blots were exposed in a luminescence imager (Peqlab/VWR, Germany). Expression 
levels of mTRPM6 were examined using a guinea pig anti-mTRPM6 polyclonal antibody (ab47017, Abcam; 
1:4000) and a horseradish peroxidase-coupled anti-guinea pig lgG (Acris; 1:1000). Western blot assessment of 
mTRPM7 was performed analogously to mTRPM6 using a rabbit anti-TRPM7 monoclonal antibody (EPR4582, 
Abcam; 1:2000).
To assess expression levels of mTRPM6 and mTRPM7 in the plasma membranes, HEK 293 cells cultured 
in 100-mm cell culture dishes (~70% confluency) were transiently transfected with 10 and 20 µg mTRPM6, 10 
and 20 µg mTRPM7 or co-transfected with 10 µg mTRPM6 together with 10 µg mTRPM7 (all in pIRES2-EGFP 
vector). 24 h after transfection, cells were collected by centrifugation and the cell pellets were washed twice with 
ice-cold PBS. Plasma membrane proteins were extracted using the MinuteTM plasma membrane protein isolation 
kit (Invent Biotechnologies) according to the manufacturer’s protocol. The obtained samples of plasma mem-
brane proteins (50 μl) were mixed with 50 μl 2x Laemmli buffer, heated at 70 °C for 10 min and cooled on ice. 
Next, Western blot analysis of mTRPM6 and mTRPM7 (1/3 of the plasma membrane samples) was performed 
as described above. The plasma membranes marker Na+/K+ ATPase was probed using an anti-Na+/K+ ATPase 
antibody (EP18459-HRP, Abcam; 1:5000).
Co-immunoprecipitation of mTRPM7 and mTRPM6. Experiments were performed as reported pre-
viously61 with several modifications. HEK 293 cells maintained in 100-mm cell culture dishes (~70% conflu-
ency) were transiently transfected with 10 µg mTRPM7-myc, 10 µg mTRPM6-YFP and 10 µg mTRPM5-YFP or 
co-transfected with 10 µg mTRPM7-myc together with 10 µg mTRPM7-YFP, mTRPM6-YFP and mTRPM5-YFP 
expression constructs. 24 h after transfection, cells were lysed in 1 ml of ice-cold lysis buffer (1 ml of PBS supple-
mented with 1% Triton X-100 and a protease inhibitor cocktail). Cell lysates were centrifuged at 4 °C (10 min at 
10,000 × g; 1 h at 30,000 × g) and 900 μl of the supernatants were further mixed with an anti-myc 9E10 antibody 
(M5546, Sigma-Aldrich) immobilized on Protein A/G magnetic beads (88802, Thermo Fisher Scientific). For 
immobilization, 2 μl anti-myc antibody was incubated with 20 μl (0.2 mg) Protein A/G magnetic beads in 1 ml of 
the lysis buffer overnight at 4 °C. Afterwards, magnetic beads were washed three times in 1 ml lysis buffer at 4 °C, 
collected using a magnetic stand, passed to the cell lysates (900 μl) and incubated overnight at 4 °C. Next, beads 
were washed three times in 1 ml lysis buffer, collected using a magnetic stand, re-suspended in 100 μl 2x Laemmli 
buffer, heated at 70 °C for 10 min and cooled on ice. 1/5 of the immunoprecipitate samples and aliquots of the 
cell lysates (10 μl mixed with 10 μl 2x Laemmli buffer) were subjected to Western blot analysis as described above 
using an anti-GFP antibody (ab290, Abcam; 1:1000 in TBST with 5% (w/v) BSA) or anti-myc antibody (9B11, 
Cell Signaling Technology; 1:1000 in TBST with 5% (w/v) BSA).
Electrophysiological techniques. Patch clamp experiments were performed as reported previously49, 62, 63  
with a few modifications. Whole-cell currents were measured using an EPC10 patch-clamp amplifier and 
PatchMaster software (Harvard Bioscience). Voltages were corrected for a liquid junction potential of 10 mV. 
Currents were elicited by a ramp protocol from −100 mV to +100 mV over 50 ms acquired at 0.5 Hz and a hold-
ing potential of 0 mV. Inward and outward current amplitudes were extracted at −80 mV and +80 mV and were 
normalized to cell size as pA/pF. Capacitance was measured using the automated capacitance cancellation func-
tion of EPC10. Patch pipettes were made of borosilicate glass (Science Products) and had resistance 2–3.5 MΩ.
Unless stated otherwise, a standard extracellular solution contained (in mM): 140 NaCl, 2.8 KCl, 1 CaCl2, 
2 MgCl2, 10 HEPES-NaOH, and 11 glucose (all from Sigma-Aldrich), pH 7.2. Effects of NS8593 (Tocris), 
2-aminoethyl diphenylborinate (2-APB; Sigma-Aldrich) and naltriben (Tocris) were examined by adding the 
compounds to the standard extracellular solution. A divalent cation-free (DVF) extracellular solution contained 
(in mM) 140 NaCl, 2.8 KCl, 11 glucose, 5 Na-EDTA and 10 HEPES-NaOH, pH 7.2. In assessment of ion perme-
ation profiles of mTRPM6 and mTRPM7, the extracellular solutions contained: 10 mM HEPES-NaOH, 260 mM 
mannitole and 10 mM of individual divalent cations (ZnCl2, MgCl2, CaCl2 or BaCl2), and were adjusted to pH 
7.0 (to prevent the precipitation of ZnCl2). Solutions were adjusted to 290 mOsm using a Vapro 5520 osmometer 
(Wescor Inc).
The standard Mg2+-free intracellular ([Mg2+]i) pipette solution contained (in mM): 120 Cs-glutamate, 8 
NaCl, 10 Cs-EGTA, 5 Cs-EDTA, 10 HEPES-CsOH, pH 7.2. In some measurements, we varied free [Mg2+]i lev-
els as follows. A nominally [Mg2+]i-free intracellular solution contained (in mM) 140 Cs-glutamate, 8 NaCl, 10 
HEPES-CsOH, pH 7.2. A pipette solution with 1 µM free [Mg2+]i comprised (in mM): 140 Cs-glutamate, 8 NaCl, 
0.0016 MgCl2, 10 Cs-EGTA, 10 HEPES-CsOH, pH 7.2. An intracellular solution with 2 mM free [Mg2+]i con-
tained (in mM): 120 Cs-glutamate, 8 NaCl, 2 Cs-EDTA, 10 HEPES-CsOH, 4 MgCl2, pH 7.2. A pipette solution 
with 210 µM Mg·ATP and 10 µM free [Mg2+]i contained (in mM): 140 Cs-glutamate, 8 NaCl, 3 Cs-EDTA, 10 
HEPES-CsOH, 2.5 Mg·ATP (Sigma-Aldrich), pH 7.2. Concentrations of [Mg·ATP]i and free [Mg2+]i were calcu-
lated using WebMaxC (maxchelator.stanford.edu).
Data are presented as means ± standard error of the mean (SEM). Data showed normal distribution. 
Unless indicated differently, data were compared by a two-tailed t-test. For multiple comparisons in Fig. 2D, 
Supplementary Fig. S7, and Supplementary Fig. S9, ANOVA (GraphPad Prism 6.0 software) was used. 
Significance was accepted at P ≤ 0.05.
To determine [Mg2+]i and [Mg·ATP]i dose responses, the intracellular pipette solutions were prepared as 
outlined in Supplementary Table S1 and Supplementary Table S2, respectively. To determine IC50 values for 
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inhibitory effects of [Mg·ATP]i and [Mg2+]i on mTRPM6 and mTRPM7 currents, data were fitted with the fol-
lowing equation:
= + − × +E(c) E (E E ) (1/(1 (IC /c) ))min max min 50
h
with E being the effect/current at a given concentration c of inhibitor, Emin the minimal effect/current, Emax the 
maximally achievable effect, IC50 the half-maximal concentration and h the Hill factor. Statistical analysis of 
dose-response curves and IC50 values (Fig. 8C and Fig. 9C) was performed using the extra sum-of-squares F test 
with the threshold P ≤ 0.05 (GraphPad Prism 6.0).
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